371 results on '"Varenhorst, Eberhard"'
Search Results
2. Randomised prostate cancer screening trial: 20 year follow-up
3. Prostate Cancer Screening
4. Clinical characteristics and quality-of-life in patients surviving a decade of prostate cancer with bone metastases
5. PSA Kinetics Provide Improved Prediction of Survival in Metastatic Hormone-Refractory Prostate Cancer
6. Prediction of Survival of Metastatic Prostate Cancer Based on Early Serial Measurements of Prostate Specific Antigen and Alkaline Phosphatase
7. Cohort Profile: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0
8. Treatment with curative intent and survival in men with high-risk prostate cancer. A population-based study of 11 380 men with serum PSA level 20–100 ng/mL
9. Duration of Testosterone Suppression after a 9.45 mg Implant of the GnRH-Analogue Buserelin in Patients with Localised Carcinoma of the Prostate: A 12-Month Follow-up Study
10. Diffusion and Economic Consequences of Health Technologies in Prostate Cancer Care in Sweden, 1991–2002
11. Estrogen-Dependent Signaling in a Molecularly Distinct Subclass of Aggressive Prostate Cancer
12. the Impact of Prostate-Specific Antigen Level at Diagnosis on the Relative Survival of 28,531 Men With Localized Carcinoma of the Prostate
13. Clinical and Economics Conditions in the Treatment of Prostate Cancer
14. The patientʼs choice of androgen-deprivation therapy in locally advanced prostate cancer: bicalutamide, a gonadotrophin-releasing hormone analogue or orchidectomy
15. The National Prostate Cancer Register in Sweden 1998—2002: Trends in incidence, treatment and survival
16. Survival in prostate carcinoma—Outcomes from a prospective, population-based cohort of 8887 men with up to 15 years of follow-up: Results from three counties in the population-based National Prostate Cancer Registry of Sweden
17. Clinical Consequences of Screening for Prostate Cancer: 15 Years Follow-up of a Randomised Controlled Trial in Sweden
18. Costs and Effects of Prostate Cancer Screening in Sweden: A 15-year follow-up of a randomized trial
19. The Estimated Economic Value of the Welfare Loss due to Prostate Cancer Pain in a Defined Population
20. Non-systematic Screening for Prostate Cancer in Sweden: Survey from the National Prostate Cancer Registry
21. Technological Changes in the Management of Prostate Cancer Result in Increased Healthcare Costs: A Retrospective Study in a Defined Swedish Population
22. Validity of a Population-Based Cancer Register in Sweden: An Assessment of Data Reproducibility in the South-East Region Prostate Cancer Register
23. Prognostic Factors and Survival in Node-Positive (N1) Prostate Cancer—A Prospective Study Based on Data from a Swedish Population-Based Cohort
24. Prostate carcinoma trends in three counties in Sweden 1987-1996: results from a population-based National Cancer Register
25. Molecular sampling of prostate cancer: a dilemma for predicting disease progression
26. Clinical and prognostic significance of changes in haemoglobin concentration during 1 year of androgen-deprivation therapy for hormone-naive bone-metastatic prostate cancer
27. MOMENTARY INCREASE IN PLASMA CALCITONIN GENE-RELATED PEPTIDE IS INVOLVED IN HOT FLASHES IN MEN TREATED WITH CASTRATION FOR CARCINOMA OF THE PROSTATE
28. PROSPECTIVE EVALUATION OF HOT FLASHES DURING TREATMENT WITH PARENTERAL ESTROGEN OR COMPLETE ANDROGEN ABLATION FOR METASTATIC CARCINOMA OF THE PROSTATE
29. Long-term survival in a swedish population-based cohort of men with prostate cancer
30. Screening for carcinoma of the prostate by digital rectal examination in a randomly selected population
31. Screening For Carcinoma Of The Prostate [with Reply]
32. Predictors of early androgen deprivation treatment failure in prostate cancer with bone metastases
33. Clinical presentation and predictors of survival related to extent of bone metastasis in 900 prostate cancer patients
34. The Long-term Disease-specific Mortality of Low-risk Localized Prostate Cancer: A Prospective Population-based Register Study Over Two Decades
35. The Long-term Disease-specific Mortality of Low-risk Localized Prostate Cancer: A Prospective Population-based Register Study Over Two Decades
36. The effects of orchiectomy, oestrogens and cyproterone-acetate on the antithrombin-III concentration in carcinoma of the prostate
37. Gonadotropine und Nebennierenrindenhormone bei Hitzewallungen nach bilateraler Orchidektomie wegen Prostatakarzinoms
38. Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostate cancer
39. Significance of pretreatment cardiovascular morbidity as a risk factor during treatment with parenteral oestrogen or combined androgen deprivation of 915 patients with metastasized prostate cancer : Evaluation of cardiovascular events in a randomized trial
40. Significance of pretreatment cardiovascular morbidity as a risk factor during treatment with parenteral oestrogen or combined androgen deprivation of 915 patients with metastasized prostate cancer:evaluation of cardiovascular events in a randomized trial
41. Inflammation, focal atrophic lesions, and prostatic intraepithelial neoplasia with respect to risk of lethal prostate cancer
42. Letter: PROSTATE CANCER SCREENING Authors reply
43. Focal Prostate Atrophic Lesions and Risk of Lethal Prostate Cancer in LABORATORY INVESTIGATION, vol 91, issue , pp 187A-187A
44. Tumour Grade, Treatment, and Relative Survival in a Population-based Cohort of Men with Potentially Curable Prostate Cancer
45. Molecular sampling of prostate cancer: a dilemma for predicting disease progression
46. Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer : part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5.
47. Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer : Part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5
48. Reliability of death certificates in prostate cancer patients
49. Letter: Prostate cancer screening
50. The impact of prostate-specific antigen level at diagnosis on the relative survival of 28,531 men with localized carcinoma of the prostate
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.